Delta Care Rx Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Delta Care Rx's estimated annual revenue is currently $21.3M per year.(i)
  • Delta Care Rx's estimated revenue per employee is $273,154

Employee Data

  • Delta Care Rx has 78 Employees.(i)
  • Delta Care Rx grew their employee count by -11% last year.

Delta Care Rx's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Pharmacy ServicesReveal Email/Phone
3
National Director Client StrategiesReveal Email/Phone
4
National Clinical Innovation OfficerReveal Email/Phone
5
Call Center Operations ManagerReveal Email/Phone
6
Clinical PharmacistReveal Email/Phone
7
Concierge ePrescribe SupervisorReveal Email/Phone
8
PharmacistReveal Email/Phone
9
Pharmacy InternReveal Email/Phone
10
Pharmacy TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M1928%N/AN/A
#2
$81.8M3463%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M178-3%N/AN/A
#6
$13.1M50-7%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M68-4%N/AN/A
#9
$67.9M40230%N/AN/A
#10
$14.9M51-16%N/AN/A
Add Company

What Is Delta Care Rx?

Delta Care, http://www.deltacarerx.com, transforms and improves the hospice pharmacy industry through business transparency, innovation, extreme customer service, and the maintenance of vital community-pharmacy relationships. As a pharmacist owned, privately held provider, Delta Care sets the industry benchmark for pharmacy benefit management, on-demand pharmacist services, and hospice tailored electronic prescribing that now features telemedicine options. Additionally, Delta Care offers tools and technologies, including telemedicine, to simplify essential workflow and ordering processes within hospice settings.

keywords:N/A

N/A

Total Funding

78

Number of Employees

$21.3M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9M7818%N/A
#2
$7.5M78-5%N/A
#3
$35M78123%N/A
#4
$24.8M7810%N/A
#5
$3.5M7850%N/A